Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says Catalent’s Nathan Bennette at AAPS PharmSci ...

Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...

AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

Expertise in CMC (chemistry, manufacturing, and control) ensures the appropriate manufacture of a pharmaceutical or biologic by coordinating material characterization, formulation development, and ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

Small Pharma is evaluating the best way to administer N,N-dimethyltryptamine (DMT) in a therapeutic setting for the treatment of depressive disorders. DMT—the primary psychoactive compound in ...

LONDON--(BUSINESS WIRE)--The Pharmaceutical Formulation Equipment market will register an incremental spend of about USD 7.35 billion, growing at a CAGR of 8.42% during the five-year forecast period.

OTTAWA, ON / ACCESSWIRE / June 3, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV:TBP)(OTCQB:TBPMF) and Altus Formulation Inc. ("Altus") today announced the launch of TALLC Corporation ...

Ascletis Pharma Inc, a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases, ...

MONTREAL and DUBAI, United Arab Emirates, June 18, 2024 (GLOBE NEWSWIRE) -- Spektar Therapeutics FZCO (“Spektar”) and Altus Formulation Inc. (“Altus”) today announced the launch of Spektus Pharma Inc.